Eliminate the Impact of Instrument-Related PFAS Interferences

LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities

This app note describes a non ion-pairing reversed-phase LC/MS method for highly modified ASOs, DNA, sgRNA, and siRNA ranging from 14- to 103-mer oligonucleotides.

Batch Reproducibility and Effect of Gradient Delay Volume on Impurity Separations of Chlorhexidine Digluconate

This application note demonstrates a liquid chromatography/quadrupole time-of-flight mass spectrometer (LC/Q-TOF MS) workflow for the identification and characterization of therapeutic peptides.

Phenomenex, Inc.

January 13th 2025

REVOLUTIONIZE YOUR LAB WORK: Introducing the Compact and Portable Autosampler for the Axcend Focus LC®

An optimized liquid chromatography (LC) method offers improved impurity separation, no batch reproducibility issues, and is unaffected by changes in gradient delay volume settings.

Related Content

Axcend

January 16th 2025

GC and GC/MS Frequently Asked Questions

January 15th 2025

Robust Column Performance for Wide Pore Size Exclusion Columns for Adeno-Associated Virus Particles (AAVs) Analysis

Analysis of Oligonucleotides Using an Ion-Pairing-Free Reversed-Phase Method with TOF LC/MS

This application note demonstrates the superior resolution and recovery of Agilent AdvanceBio SEC 500 Å columns when compared with competitor products for AAVs.

LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities

This app note describes a non ion-pairing reversed-phase LC/MS method for highly modified ASOs, DNA, sgRNA, and siRNA ranging from 14- to 103-mer oligonucleotides.

Batch Reproducibility and Effect of Gradient Delay Volume on Impurity Separations of Chlorhexidine Digluconate

This application note demonstrates a liquid chromatography/quadrupole time-of-flight mass spectrometer (LC/Q-TOF MS) workflow for the identification and characterization of therapeutic peptides.

Phenomenex, Inc.

January 13th 2025